Bioventus Class A Inc (BVS) returns
Bioventus Class A returns over 5 years
$1,000 invested in Bioventus Class A five years ago was worth $882.45 at the close on October 30, 2026, with dividends reinvested: an average return of -2.5% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -2.2% | — | $977.62 | -0.9% |
| 3 months | +1.1% | — | $1,011 | +2.1% |
| Year to date | +79.1% | — | $1,791 | +11.7% |
| 1 year | +96.8% | — | $1,968 | +12.4% |
| 3 years | +276.4% | +55.6% | $3,764 | +88.5% |
| 5 years | -11.8% | -2.5% | $882.45 | +76.0% |
Bioventus Class A return by calendar year
| Year | BVS | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +79.1% | +11.7% | +67.4% |
| 2025 | -29.1% | +17.7% | -46.9% |
| 2024 | +99.2% | +24.9% | +74.4% |
| 2023 | +101.9% | +26.2% | +75.7% |
| 2022 | -82.0% | -18.2% | -63.8% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: BVS financials · BVS valuation
No forecast, no recommendation. This page describes Bioventus Class A Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.